UNC-2025(1429881-91-3)名称与标识符
名称
中文别名：
UNC2025 抑制剂;反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇;UNC2025;反式-4-(2-(丁胺基)-5-(4-((4-甲基哌嗪-1-基)甲基)苯基)-7H-吡咯并[2,3-d]嘧啶-7-基)环己醇;
英文别名：
trans-4-(2-(Butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol;UNC 2025;UNC-2025(UNC2025);UNC-2025;UNC2025;(1r,4r)-4-(2-(butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol;AK171371;4-(2-(Butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexan-1-ol;BCP16544;BDBM50055496;SB16838;BC600567;4-[2-(Butylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexa;UNC2025?;CHEMBL3326006;mrx-6313;EX-A1030;NCGC00390618-01;CS-3354;4-[2-(butylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol;NCGC00390618-04;NCGC00482875-01;SCHEMBL15978986;BDBM350845;US9795606, B4;SCHEMBL14854194;BRD-K91283740-003-01-6;1429881-91-3;AS-52179;AKOS025289796;DA-44845;s9662;HY-12344;SCHEMBL21797957;MFCD28142874;P14544;NCGC00390618-02;(1r,4r)-4-[2-(butylamino)-5-{4-[(4-methylpiperazin-1-yl)methyl]phenyl}-7H-pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol;4-[2-(butylamino)-5-{4-[(4-methylpiperazin-1-yl)methyl]phenyl}pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol;AC-35301;UNC2025A;2109176-09-0;
标识符
InChIKey：
MJSHVHLADKXCML-UHFFFAOYSA-N
Inchi：
1S/C28H40N6O/c1-3-4-13-29-28-30-18-25-26(20-34(27(25)31-28)23-9-11-24(35)12-10-23)22-7-5-21(6-8-22)19-33-16-14-32(2)15-17-33/h5-8,18,20,23-24,35H,3-4,9-17,19H2,1-2H3,(H,29,30,31)
SMILES：
O([H])C1([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C1([H])[H])N1C([H])=C(C2C([H])=C([H])C(=C([H])C=2[H])C([H])([H])N2C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C2([H])[H])C2=C([H])N=C(N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])N=C12
1724405207 
